Josep Mallolas Masferrer at University of Barcelona - Research Interests, Publications & Academic Profile

Josep Mallolas Masferrer

Professor of Medicina

University of Barcelona

Spain

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Korean students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Virology

40%

Pharmacotherapy

30%

Hiv

50%

Covid-19

30%

Sexual Health

30%

Antiviral Therapy

30%

Drug Repurposing

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles10

Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life-Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain.

Article Link

Year:

2022

Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre

Article Link

Year:

2022

Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4<sup>+</sup> T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy

Article Link

Year:

2022

Vulnerability Conditions in a Cohort of Men Who Have Sex with Men Who Engage in Chemsex in Barcelona City: a Cross-Sectional Study

Article Link

Year:

2022

Correction to: Impact of Sexualized Substance Use and Other Risk Practices on HCV Microelimination in gbMSM Living with HIV: Urgent Need for Targeted Strategies. Results of a Retrospective Cohort Study (Infectious Diseases and Therapy, (2021), 10, 3, (1253-1266), 10.1007/s40121-021-00448-0)

Article Link

Year:

2022

Clinical Presentation and Outcome of COVID-19 in a Latin American Versus Spanish Population: Matched Case-Control Study

Article Link

Year:

2022

Impact of SARS-CoV-2 viral load and duration of symptoms before hospital admission on the mortality of hospitalized COVID-19 patients

Article Link

Year:

2022

Impact of coronavirus disease 2019 epidemics on prevention and care for HIV and other sexually transmitted infections

Article Link

Year:

2022

Long-term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in hepatitis C virus-human immunodeficiency virus co-infected patients

Article Link

Year:

2022

Simplification from tenofovir disoproxil fumarate plus lamivudine or emtricitabine plus ritonavir-boosted protease inhibitor to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed HIV-infected adults with osteopenia: a pilot study

Article Link

Year:

2022

Collaborators6

FREDERIC GOMEZ

Associate Professor

SPAIN

Yuliya Poliakova Mazneva

Head of Department

SPAIN

Maria-Jesus Pinazo

Head

SWITZERLAND

Montserrat Laguno Centeno

Institut d'Investigacions Biomèdiques August Pi i Sunyer

SPAIN

David Garcia-Hernandez

Associated Professor

Universitat Autònoma de Barcelona Facultat de Medicina

SPAIN

Yolanda María Pacheco

SPAIN

How do Korean students reach out?

Meet Kite AI